Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Rating) have been assigned a consensus rating of “Hold” from the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $57.10.
Several equities research analysts have weighed in on TRUP shares. StockNews.com started coverage on Trupanion in a report on Thursday, May 18th. They issued a “sell” rating for the company. Jefferies Financial Group dropped their price objective on Trupanion from $75.00 to $65.00 and set a “buy” rating for the company in a report on Tuesday, March 28th. Lake Street Capital dropped their price objective on Trupanion from $75.00 to $47.00 in a report on Friday, May 5th. Piper Sandler dropped their price objective on Trupanion from $44.00 to $33.00 in a report on Friday, May 5th. Finally, Stifel Nicolaus dropped their price objective on Trupanion from $51.00 to $37.00 and set a “hold” rating for the company in a report on Friday, April 21st.
Insider Transactions at Trupanion
In other news, CEO Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $25.30, for a total value of $101,200.00. Following the completion of the transaction, the chief executive officer now owns 829,109 shares of the company’s stock, valued at approximately $20,976,457.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Howard E. Rubin sold 3,500 shares of the stock in a transaction that occurred on Tuesday, February 28th. The stock was sold at an average price of $58.85, for a total value of $205,975.00. Following the completion of the transaction, the director now owns 227,855 shares of the company’s stock, valued at approximately $13,409,266.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $25.30, for a total value of $101,200.00. Following the transaction, the chief executive officer now directly owns 829,109 shares of the company’s stock, valued at approximately $20,976,457.70. The disclosure for this sale can be found here. In the last quarter, insiders sold 26,250 shares of company stock valued at $1,176,975. Corporate insiders own 5.86% of the company’s stock.
Institutional Inflows and Outflows
Trupanion Trading Down 3.5 %
Shares of TRUP stock opened at $20.64 on Tuesday. The stock has a market capitalization of $850.78 million, a PE ratio of -13.95 and a beta of 1.70. Trupanion has a 1-year low of $19.64 and a 1-year high of $82.49. The business has a 50-day moving average of $34.91 and a 200 day moving average of $47.53. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.64 and a quick ratio of 1.64.
Trupanion (NASDAQ:TRUP – Get Rating) last issued its earnings results on Thursday, May 4th. The financial services provider reported ($0.60) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.32). The company had revenue of $256.33 million for the quarter, compared to analysts’ expectations of $251.88 million. Trupanion had a negative net margin of 6.34% and a negative return on equity of 19.86%. As a group, sell-side analysts anticipate that Trupanion will post -1.65 earnings per share for the current year.
Trupanion Company Profile
Trupanion, Inc engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members.
Featured Stories
- Get a free copy of the StockNews.com research report on Trupanion (TRUP)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.